Bank Julius Baer & Co
NVO

Bank Julius Baer & Co’s Novo Nordisk NVO Stock Holding History

Bank Julius Baer & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.5K Sell
1,373
-2,693
-66% -$128K ﹤0.01% 599
2025
Q4 		$207K Buy
4,066
+2,693
+196% +$138K ﹤0.01% 484
2025
Q3 		$76.2K Hold
1,373
– – ﹤0.01% 560
2025
Q2 		$94.8K Buy
+1,373
New +$93.4K ﹤0.01% 501

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Bank Julius Baer & Co's NVO Position: Q1 2026 in Review

Bank Julius Baer & Co reduced its Novo Nordisk (NVO) stake by 66% in Q1 2026, selling an estimated $128K and leaving 1,373 shares worth $50.5K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

Bank Julius Baer & Co first reported a position in NVO in Q2 2025 and has held it in 4 quarters since. The position peaked at $207K in Q4 2025. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Bank Julius Baer & Co held 1,373 shares of Novo Nordisk worth $50.5K as of Q1 2026.
  • Bank Julius Baer & Co sold 2,693 Novo Nordisk shares in Q1 2026, an estimated $128K.
  • Novo Nordisk made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q1 2026, its #599 holding.
  • Bank Julius Baer & Co first reported a position in Novo Nordisk in Q2 2025 and has held it in 4 quarters since.
  • Bank Julius Baer & Co's Novo Nordisk position peaked at $207K in Q4 2025.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.